Stock Information
Verastem Inc (VSTM)
Ticker Symbol: VSTM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $720.56 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.46
Revenue (TTM): $0.87 M
Dividend Yield: N/A
ROE: -165.4%
Latest News
-
Verastem Oncology Announces Publication in Gynecologic Oncology of Two-Year Median Follow-Up Data from RAMP 201 Study of AVMAPKI® FAKZYNJA® CO-PACK (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cancer
Mon, Sep 28, 2026 8:10 PM
-
KRAS Inhibitor Market Projected to Reach $7.8 Billion by 2034
Mon, Sep 28, 2026 12:00 PM
-
Verastem Oncology Announces Late-Breaking Oral Presentation of RAMP 201 Low-Grade Serous Ovarian Cancer Molecular Profiling and Tumor Biomarker Analysis at IGCS 2026 Annual Global Meeting
Thu, Sep 24, 2026 12:30 PM
-
Verastem Highlights Ovarian Cancer Launch, KRAS G12D Program at H.C. Wainwright
Tue, Sep 22, 2026 3:02 AM
Key Financials
Financial data not available
